Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Single-cell Technologies Market: By Cell Type, By Product, By Technique, By Application, By End User, and Geography
Single-cell Technologies Market: By Cell Type, By Product, By Technique, By Application, By End User, and Geography
Single-Cell Technologies Market size was valued at US$ 3.7 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 15.6% from 2024 to 2030 to reach US$ 10.2 billion in 2030. The market refers to the industry involved in technologies that enable the study and analysis of individual cells at a molecular level. The applications of single-cell technologies are diverse and span across various fields such as cancer research, immunology, developmental biology, neurology, and personalized medicine. These technologies are crucial for understanding cellular diversity, identifying rare cell types, studying disease mechanisms, and discovering new biomarkers and drug targets.
The growth of the market is fueled by its increasing use in diagnosing diseases and discovering & developing drugs. It benefits from the profitable advancement of sequencing technology, ongoing innovations in single-cell analysis and cell isolation techniques, and a rising prevalence of cancer. The escalating global mortality rates attributed to cancer further underscore the importance of single-cell analysis in disease diagnosis and treatment. Automation of workflows is also anticipated to contribute to market growth. However, in maintaining high-quality standards (i.e., the use of high-grade expensive items) and abiding by the regulatory rules, single-cell biology research proves to be highly expensive, which is obstructing market growth.
Study Period
2024-2030Base Year
2023CAGR
10.2%Largest Market
North AmericaFastest Growing Market
Asia Pacific
The growth of the single-cell analysis market is driven by advancements in technology related to single-cell analysis products, increased investments in cancer research, and expansion of the biotechnology and biopharmaceutical sectors in recent years. Cancer remains a leading cause of death globally, with significant growth observed in recent years and anticipated to continue over the forecast period. According to the World Health Organization (WHO), cancer accounted for nearly 10 million deaths in 2020, representing approximately one in six deaths worldwide. The incidence of cancer varies widely between countries, further boosting demand for advanced diagnostic tools and accelerating market growth.
The International Agency for Research on Cancer (IARC) forecasts a substantial increase in global cancer cases and deaths by 2040, underscoring the urgent need for enhanced diagnostic capabilities. Circulating tumor cells are gaining clinical importance as they offer insights into cancer progression and potential adjustments to treatment strategies. Single-cell sequencing analysis has emerged as a valuable tool for identifying diagnostic and prognostic biomarkers. In clinical diagnostics, it is expected to streamline and automate workflows, providing real-time monitoring of cancer and facilitating the development of new therapeutic approaches for patients. Increased investments in cancer research are thus a pivotal factor expected to drive market growth in the coming years.
The single-cell analysis market in North America is projected to experience significant growth due to the rising adoption of genomic medicines, biopharmaceuticals, and advanced technologies like next-generation sequencing in the United States and Canada for diagnosing and treating clinical conditions. Additionally, increased utilization of genomic, proteomic, and cell biology platforms in the region is driving the demand for single-cell analysis tools.
Europe has witnessed several developments in stem cell research, cell therapy, personalized medicine, biopharmaceutical development, and proteomics. This is due to several initiatives undertaken by the government and non-government organizations to boost the biotechnology sector's growth in the region.
The Asia Pacific region is experiencing rapid growth, driven by its expanding economy, rising elderly population, and increasing investments in biotechnology. Key drivers include growing demand for biotech tools in research and development, greater adoption of laboratory automation, and increasing government focus on biotechnology and healthcare sectors.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 3.7 billion |
|
Market Size in 2030 |
US$ 10.2 billion |
|
Market CAGR |
10.2% |
|
By Cell Type |
|
|
By Product Type |
|
|
By Technique |
|
|
By Application |
|
|
By End User |
|
|
By Region |
|
Download Free Sample Report
Single-cell technologies market size was valued at US$ 3.7 billion in 2023 and is expected to grow at a (CAGR) of 15.6% from 2024 to 2030
The market is segmented based on cell type, product type, technique, application end-user, and geography
The leading players in the single-cell technologies market are Thermo Fisher Scientific, Inc., QIAGEN NV, Bio-Rad Laboratories, Inc., Illumina, Inc., Merck KGaA, Becton, Dickinson & Company (BD), Fluidigm Corporation (Standard BioTools Inc.), 10x Genomics, Inc., BGI, Novogene Co, Ltd., Active Motif, Admera Health, Annoroad Genomics, CD Genomics, MedGenome, SingulOmics,10x Genomics, and Cell Microsystems.
The market in North America is projected to experience significant growth due to the rising adoption of genomic medicines, biopharmaceuticals, and advanced technologies like next-generation sequencing in the United States and Canada for diagnosing and treating clinical conditions. Additionally, increased utilization of genomic, proteomic, and cell biology platforms in the region is driving the demand for single-cell analysis tools.
The Asia Pacific region is experiencing rapid growth, driven by its expanding economy, rising elderly population, and increasing investments in biotechnology. Key drivers include growing demand for biotech tools in research and development, greater adoption of laboratory automation, and increasing government focus on biotechnology and healthcare sectors.
| 1.Executive Summary |
| 2.Global Single-cell Technologies Market Introduction |
| 2.1.Global Single-cell Technologies Market - Taxonomy |
| 2.2.Global Single-cell Technologies Market - Definitions |
| 2.2.1.Cell Type |
| 2.2.2.Product Type |
| 2.2.3.Technique |
| 2.2.4.Application |
| 2.2.5.Region |
| 3.Global Single-cell Technologies Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Single-cell Technologies Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Single-cell Technologies Market By Cell Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Human |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Animal |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Microbial |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6.Global Single-cell Technologies Market By Product Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Consumables |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Instrument |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 7.Global Single-cell Technologies Market By Technique, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. Flow |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Cytometry |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. NGS |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Microscopy |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. PCR |
| 7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 7.6. MS |
| 7.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.6.3. Market Opportunity Analysis |
| 7.7. Others |
| 7.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.7.3. Market Opportunity Analysis |
| 8.Global Single-cell Technologies Market By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. Research |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Medical |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 9.Global Single-cell Technologies Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia Pacific (APAC) |
| 9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Middle East and Africa (MEA) |
| 9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Latin America |
| 9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 10.North America Single-cell Technologies Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Cell Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Human |
| 10.1.2.Animal |
| 10.1.3.Microbial |
| 10.2. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Consumables |
| 10.2.2.Instrument |
| 10.3. Technique Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Flow |
| 10.3.2.Cytometry |
| 10.3.3.NGS |
| 10.3.4.Microscopy |
| 10.3.5.PCR |
| 10.3.6.MS |
| 10.3.7.Others |
| 10.4. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Research |
| 10.4.2.Medical |
| 10.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.5.1.United States of America (USA) |
| 10.5.2.Canada |
| 11.Europe Single-cell Technologies Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Cell Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Human |
| 11.1.2.Animal |
| 11.1.3.Microbial |
| 11.2. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Consumables |
| 11.2.2.Instrument |
| 11.3. Technique Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Flow |
| 11.3.2.Cytometry |
| 11.3.3.NGS |
| 11.3.4.Microscopy |
| 11.3.5.PCR |
| 11.3.6.MS |
| 11.3.7.Others |
| 11.4. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Research |
| 11.4.2.Medical |
| 11.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.5.1.Germany |
| 11.5.2.France |
| 11.5.3.Italy |
| 11.5.4.United Kingdom (UK) |
| 11.5.5.Spain |
| 12.Asia Pacific (APAC) Single-cell Technologies Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Cell Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Human |
| 12.1.2.Animal |
| 12.1.3.Microbial |
| 12.2. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Consumables |
| 12.2.2.Instrument |
| 12.3. Technique Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Flow |
| 12.3.2.Cytometry |
| 12.3.3.NGS |
| 12.3.4.Microscopy |
| 12.3.5.PCR |
| 12.3.6.MS |
| 12.3.7.Others |
| 12.4. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Research |
| 12.4.2.Medical |
| 12.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.5.1.China |
| 12.5.2.India |
| 12.5.3.Australia and New Zealand (ANZ) |
| 12.5.4.Japan |
| 12.5.5.Rest of APAC |
| 13.Middle East and Africa (MEA) Single-cell Technologies Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 13.1. Cell Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Human |
| 13.1.2.Animal |
| 13.1.3.Microbial |
| 13.2. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Consumables |
| 13.2.2.Instrument |
| 13.3. Technique Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Flow |
| 13.3.2.Cytometry |
| 13.3.3.NGS |
| 13.3.4.Microscopy |
| 13.3.5.PCR |
| 13.3.6.MS |
| 13.3.7.Others |
| 13.4. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Research |
| 13.4.2.Medical |
| 13.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.5.1.GCC Countries |
| 13.5.2.South Africa |
| 13.5.3.Rest of MEA |
| 14.Latin America Single-cell Technologies Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 14.1. Cell Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1.Human |
| 14.1.2.Animal |
| 14.1.3.Microbial |
| 14.2. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.Consumables |
| 14.2.2.Instrument |
| 14.3. Technique Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Flow |
| 14.3.2.Cytometry |
| 14.3.3.NGS |
| 14.3.4.Microscopy |
| 14.3.5.PCR |
| 14.3.6.MS |
| 14.3.7.Others |
| 14.4. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Research |
| 14.4.2.Medical |
| 14.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.5.1.Brazil |
| 14.5.2.Mexico |
| 14.5.3.Rest of LA |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1.Thermo Fisher Scientific, Inc. |
| 15.2.2.QIAGEN NV |
| 15.2.3.Bio-Rad Laboratories, Inc. |
| 15.2.4.Illumina, Inc. |
| 15.2.5.Merck KGaA |
| 15.2.6.Becton, Dickinson & Company (BD) |
| 15.2.7.Fluidigm Corporation |
| 15.2.8.Standard BioTools Inc. |
| 15.2.9.10x Genomics, Inc. |
| 15.2.10.BGI |
| 15.2.11.Novogene Co, Ltd. |
| 15.2.12.Active Motif |
| 15.2.13.Admera Health |
| 15.2.14.Annoroad Genomics |
| 15.2.15.CD Genomics |
| 15.2.16.MedGenome |
| 15.2.17.SingulOmics |
| 15.2.18.10x Genomics |
| 15.2.19.Cell Microsystems |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.